ArticleOsteoporosis and sarcopenia2021

Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: An open-label, randomized, pilot study.

Takeshi Mochizuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.